CDDF Annual Conference 2026

The CDDF Annual Conference addresses highly relevant topics in the development of anti-cancer drugs, fostering constructive discussions among leading experts from diverse fields central to oncology drug development. These include patient advocates, regulators from the FDA, EMA, and EU national agencies, health technology assessors, academic researchers, and the pharmaceutical industry.

This year’s programme will explore global regulatory perspectives and their impact on international trial design, strategies to improve diversity and representativeness in clinical research, and the integration of patient-relevant endpoints, including patient-reported outcomes and experience data. Attendees will also engage in discussions on innovative trial designs and the role of Big Data and federated datasets in optimizing oncology research.

Dates: 9 – 11 February 2026
Location: hybrid, Ghent (BE)